ストックスクリーナーアプリを入手
576.07
3.42%
19.05
プレマーケット:
578.00
1.93
+0.34%
Idexx Laboratories Inc (IDXX) 最新ニュース
Idexx Laboratories (IDXX) Shows Promising Growth Potential - GuruFocus
Is IDEXX Laboratories Inc (IDXX) a Bargain After 4.2% Drop? GF Value Says Undervalued - GuruFocus
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
IDEXX Laboratories earnings preview: What to expect - MSN
Donald TrumpIDEXX LABS UNSOLICITED Trump Trade on Mar. 23, 2026 - Quiver Quantitative
IDEXX Laboratories stock holds steady as diagnostics demand supports long-term growth - ad-hoc-news.de
IDEXX Laboratories Earnings Preview: What to Expect - Yahoo Finance
Leerink Partners Adjusts IDEXX Laboratories Price Target to $715 From $725, Maintains Outperform Rating - marketscreener.com
Veterinary Lab Automation Global Market Report 2023 Now Available, Covers Asia-Pacific, North America, Europe, and More - GlobeNewswire Inc.
IDEXX Laboratories focuses on diagnostics growth. Investors watch demand trends - ad-hoc-news.de
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IDEXX Laboratories extends its diagnostics reach as a key S&P 500 health-tech name - ad-hoc-news.de
IDEXX Laboratories Does Not Need More Vet Visits, But It Needs More Tests Per Visit (IDXX) - Seeking Alpha
William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating - Moomoo
IDEXX Laboratories focuses on diagnostics growth. Business model supports long-term demand - ad-hoc-news.de
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Laboratories Stock: $876 Target Backed by Cancer Dx Adoption Across 7,500 Practices - TIKR.com
IDEXX Laboratories stock holds its focus on diagnostics. Investors watch the business mix. - AD HOC NEWS
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring a Potential 27% Upside for Investors - DirectorsTalk Interviews
The SNAP Pro AnalyzerIDEXX Laboratories leans on faster point-of-care diagnostics - ad-hoc-news.de
IDEXX Laboratories stock tracks its core diagnostics business - ad-hoc-news.de
IDXXIdexx Laboratories Inc Volatility & Greeks - Finviz
Enterprise value to EBIT forward of IDEXX Laboratories, Inc. – NASDAQ:IDXX - TradingView
IDEXX Laboratories stock leans on its diagnostics base - Ad-hoc-news.de
IDEXX Laboratories focuses on diagnostics growth as investors watch long-term demand - ad-hoc-news.de
Price to sales forward of IDEXX Laboratories, Inc. – NASDAQ:IDXX - TradingView
IDEXX Laboratories outlook as a diagnostics leader - ad-hoc-news.de
Price to earnings forward of IDEXX Laboratories, Inc. – NASDAQ:IDXX - TradingView
Does IDEXX Laboratories (NASDAQ:IDXX) Deserve A Spot On Your Watchlist? - Moomoo
EULAV Asset Management's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
IDEXX Laboratories Inc (IDXX) Stock Up 3.8% and Still Undervalued -- GF Score: 96/100 - GuruFocus
IDEXX Laboratories to Release 2026 Second Quarter Financial Results - 01net
Press Release: IDEXX Laboratories to Release 2026 Second Quarter Financial Results - Moomoo
IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors - MarketWatch
IDEXX Laboratories, Inc.(NasdaqGS: IDXX) added to Russell Midcap Value Benchmark - marketscreener.com
Is the Options Market Predicting a Spike in IDEXX Laboratories Stock? - Zacks Investment Research
Is IDEXX Laboratories stock underperforming the Nasdaq? - MSN
IDEXX Laboratories (IDXX) Stock Analysis: Uncovering a Potential 28.58% Upside for Investors - DirectorsTalk Interviews
IDEXX Laboratories with a clear strategy focus, shares anchored in the NASDAQ-100 - AD HOC NEWS
IDEXX Laboratories, Inc.(NasdaqGS: IDXX) added to Russell 1000 Value Benchmark - marketscreener.com
The Catalyst Dx from IDEXX Laboratories Inc.compact chemistry analyzer for fast in-clinic results - AD HOC NEWS
IDEXX Laboratories, Inc.(NasdaqGS: IDXX) added to Russell 1000 Value-Defensive Index - marketscreener.com
IDEXX Laboratories opens the week with a clear consensus, NASDAQ-100 shares in a steady trend - Ad-hoc-news.de
IDEXX Laboratories focuses on long-term growth, shares in NASDAQ-100 healthcare peer group - Ad-hoc-news.de
New diagnostic test for kidney injury - DVM360
IDEXX Laboratories opens the week with earnings focus, shares steady - Ad-hoc-news.de
IDEXX Laboratories, Inc. Actuals & Estimates (NASDAQ:IDXX) - TradingView
IDEXX Laboratories, Inc. Actuals & Estimates (VIE:IDXX) - TradingView
IDXX Forecast — Price Target — Prediction for 2027 - TradingView
IDEXX Laboratories sets the pace with raised 2026 guidance, analysts back the stock - Ad-hoc-news.de
Enterprise value to EBITDA forward of IDEXX Laboratories, Inc. – DUS:IX1 - TradingView
Why IDEXX Laboratories Stock Looks Undervalued After Raising Its 2026 EPS Outlook to $15 - TIKR.com
Are IDEXX Laboratories’ (IDXX) New SDMA and Tapeworm Tests Deepening Its Diagnostics Moat? - Sahm
IDEXX Laboratories Inc (IDXX) Institutional Confidence - TradingKey
Price to book forward of IDEXX Laboratories, Inc. – NASDAQ:IDXX - TradingView
Enterprise value to revenue forward of IDEXX Laboratories, Inc. – NASDAQ:IDXX - TradingView
IDEXX Laboratories analyst consensus stays firm, shares trade below recent high - Ad-hoc-news.de
IDEXX Laboratories Inc (IDXX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
SNAP 4Dx Plus Test from IDEXX Laboratoriesquick tick-borne screening in minutes - Ad-hoc-news.de
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999. - marketscreener.com
2.72%
1.03%
大文字化:
|
ボリューム (24 時間):